Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP1,Low molecular weight phosphotyrosine protein phosphatase,19566,122,0.56 [0.36-0.86],0.008111203245585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTA2,"Actin, aortic smooth muscle",22843,165,1.51 [1.19-1.93],0.0007563836814616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN2,Alpha-actinin-2,19476,122,1.34 [1.06-1.70],0.0158458499947668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACVRL1,Serine/threonine-protein kinase receptor R3,23021,168,2.85 [1.84-4.42],2.954716898337917e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA2,Adenosine deaminase 2,23148,170,1.75 [1.32-2.32],0.0001047034246439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19566,122,1.95 [1.29-2.94],0.0014291883852101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22843,165,1.60 [1.03-2.48],0.0350156896673296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,23435,168,1.68 [1.09-2.57],0.018294050693588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,23559,171,0.56 [0.33-0.97],0.0375299038957831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,23327,169,0.70 [0.52-0.94],0.0180324835736335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADD1,Alpha-adducin,19710,123,0.77 [0.60-0.98],0.0366587814821112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE1,Adhesion G protein-coupled receptor E1,20100,129,1.64 [1.24-2.19],0.0006066246971014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE2,Adhesion G protein-coupled receptor E2,23346,169,1.67 [1.05-2.65],0.0289218179017223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADM,Pro-adrenomedullin,23465,170,2.05 [1.21-3.46],0.0072522115733971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFAP1,Actin filament-associated protein 1,19710,123,0.77 [0.61-0.97],0.024967459980613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGBL2,Cytosolic carboxypeptidase 2,19511,122,1.23 [1.01-1.48],0.0371366503751556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR2,Anterior gradient protein 2 homolog,22580,161,1.19 [1.04-1.37],0.0145149753405158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRN,Agrin,23346,169,1.77 [1.28-2.44],0.0005311400263395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",23120,167,1.16 [1.02-1.31],0.0243190015069294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1C4,Aldo-keto reductase family 1 member C4,22843,165,1.29 [1.05-1.59],0.0162116540012908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALCAM,CD166 antigen,23559,171,2.39 [1.24-4.60],0.0092655265526043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBP,Protein AMBP,23430,170,3.45 [1.84-6.47],0.000112472552169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMFR,E3 ubiquitin-protein ligase AMFR,22749,164,1.40 [1.18-1.66],0.0001139823940779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO2,Amphoterin-induced protein 2,23153,167,1.84 [1.04-3.25],0.0361902133478811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMPD3,AMP deaminase 3,20115,129,0.74 [0.58-0.93],0.0116025362344222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18936,123,0.62 [0.42-0.89],0.0104402937080432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT2,Angiopoietin-2,23465,170,1.53 [1.08-2.16],0.0155295716925279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL4,Angiopoietin-related protein 4,23310,169,1.51 [1.12-2.03],0.0074470338370833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANPEP,Aminopeptidase N,23341,171,1.66 [1.04-2.66],0.0340041788229702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA10,Annexin A10,22749,164,1.25 [1.08-1.45],0.0032291942414844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA5,Annexin A5,22667,164,1.82 [1.21-2.72],0.0036615719343114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,23153,167,1.37 [1.07-1.76],0.0119263704333874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA1,Apolipoprotein A-I,20185,128,0.41 [0.20-0.84],0.0146799122979701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOC1,Apolipoprotein C-I,20152,127,0.61 [0.39-0.97],0.0354688716086974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOF,Apolipoprotein F,20188,130,0.46 [0.28-0.75],0.0019759329086898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AREG,Amphiregulin,23153,167,2.17 [1.64-2.88],5.994672424983498e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG1,Arginase-1,23102,167,0.64 [0.49-0.83],0.0008758340244771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASAH2,Neutral ceramidase,23062,169,0.79 [0.64-0.99],0.0410572223351034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR1,Asialoglycoprotein receptor 1,23062,169,1.98 [1.33-2.93],0.0007184784730036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5PO,"ATP synthase subunit O, mitochondrial",22749,164,1.33 [1.03-1.73],0.0298257656610603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6AP2,Renin receptor,22716,165,1.43 [1.09-1.88],0.0106747646321586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN3,Ataxin-3,20115,129,0.75 [0.57-0.99],0.0387361107271412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXL,Tyrosine-protein kinase receptor UFO,23375,171,1.93 [1.20-3.09],0.0065504761260869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B2M,Beta-2-microglobulin,20185,128,1.47 [1.09-1.99],0.01195318190811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19613,127,1.63 [1.02-2.58],0.0390862656777439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GALT1,"Beta-1,4-galactosyltransferase 1",23346,169,2.62 [1.67-4.10],2.7152300848659783e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG3,BAG family molecular chaperone regulator 3,23021,168,1.61 [1.14-2.29],0.0070403966103307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22716,165,1.34 [1.10-1.62],0.0029846950111568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAMBI,BMP and activin membrane-bound inhibitor homolog,22716,165,2.25 [1.57-3.24],1.1075089622638234e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOLA2_BOLA2B,BolA-like protein 2,19613,127,0.71 [0.52-0.98],0.0396685133486617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRK1,Protein BRICK1,22749,164,1.53 [1.15-2.05],0.0039551672584402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSG,Basigin,23498,168,2.41 [1.30-4.49],0.0054478694744647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST2,Bone marrow stromal antigen 2,23472,168,1.66 [1.36-2.03],5.326395565016365e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN2A1,Butyrophilin subfamily 2 member A1,23346,169,2.37 [1.55-3.63],7.155068455698005e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN3A2,Butyrophilin subfamily 3 member A2,23240,169,1.75 [1.34-2.29],3.993054102611174e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QA,Complement C1q subcomponent subunit A,23427,167,1.96 [1.10-3.52],0.0234634009186678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1R,Complement C1r subcomponent,20185,128,0.30 [0.10-0.90],0.0311958771584263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2,Complement C2,23341,171,2.93 [1.48-5.82],0.0021177790342142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7,Complement component C7,19698,125,2.19 [1.31-3.64],0.0027432398514668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C9orf40,Uncharacterized protein C9orf40,20100,129,0.80 [0.64-0.99],0.0364613790803967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA1,Carbonic anhydrase 1,22786,168,0.74 [0.58-0.94],0.0143947575236503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA12,Carbonic anhydrase 12,23153,167,1.89 [1.32-2.70],0.0004758466731363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA2,Carbonic anhydrase 2,23200,167,0.79 [0.64-0.97],0.0244693380128674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA6,Carbonic anhydrase 6,23206,167,0.66 [0.54-0.82],0.0001612043357851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB1,Calbindin,23153,167,1.36 [1.00-1.84],0.0464822512058652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB2,Calretinin,22749,164,1.61 [1.26-2.07],0.0001846241816621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22716,165,1.43 [1.08-1.89],0.0112414693139763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CANT1,Soluble calcium-activated nucleotidase 1,23190,169,2.10 [1.09-4.06],0.0266209677645711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPN3,Calpain-3,20093,131,1.76 [1.36-2.27],1.662724677638154e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAT,Catalase,19896,124,0.70 [0.50-0.98],0.0394055457524661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN4,Cerebellin-4,23465,170,0.52 [0.35-0.79],0.0021301581331884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC80,Coiled-coil domain-containing protein 80,23267,170,1.92 [1.37-2.70],0.0001454392998509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL20,C-C motif chemokine 20,23536,169,1.21 [1.06-1.38],0.0054617300020128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL21,C-C motif chemokine 21,23346,169,1.60 [1.23-2.07],0.00044261656712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL22,C-C motif chemokine 22,22998,168,1.49 [1.18-1.89],0.0008292571974738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL3,C-C motif chemokine 3,23240,169,1.20 [1.02-1.41],0.0322131381611109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL7,C-C motif chemokine 7,23240,169,1.27 [1.03-1.55],0.0223604176881254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN3,CCN family member 3,23514,171,2.11 [1.51-2.96],1.3194569699437943e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN4,CCN family member 4,23465,170,1.44 [1.04-1.99],0.0298586881260345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN5,CCN family member 5,23278,167,1.67 [1.19-2.36],0.0034163852009946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD14,Monocyte differentiation antigen CD14,22835,168,1.50 [1.09-2.07],0.0135166308913851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD160,CD160 antigen,23536,169,1.34 [1.03-1.76],0.0304520741217525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD163,Scavenger receptor cysteine-rich type 1 protein M130,23375,171,1.79 [1.34-2.38],6.703210822472128e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD244,Natural killer cell receptor 2B4,23536,169,2.32 [1.47-3.64],0.0002682828470815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD27,CD27 antigen,23327,169,2.03 [1.55-2.65],2.2119058538031617e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD274,Programmed cell death 1 ligand 1,23062,169,1.78 [1.27-2.51],0.0009005264178025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD276,CD276 antigen,23227,169,1.65 [1.12-2.44],0.0115908527596483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD28,T-cell-specific surface glycoprotein CD28,22716,165,1.75 [1.35-2.28],2.576263987516985e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300A,CMRF35-like molecule 8,19710,123,2.09 [1.23-3.54],0.0061533107848556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300C,CMRF35-like molecule 6,23472,168,2.12 [1.48-3.02],3.7673326222043184e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300E,CMRF35-like molecule 2,23403,170,2.33 [1.77-3.07],1.646576142048426e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LF,CMRF35-like molecule 1,23465,170,1.43 [1.13-1.82],0.0034588296037871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD302,CD302 antigen,23153,167,1.89 [1.29-2.77],0.0011605551501148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,23153,167,1.72 [1.16-2.57],0.0073091869048493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3G,T-cell surface glycoprotein CD3 gamma chain,19566,122,1.19 [1.03-1.38],0.0201744874783789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD4,T-cell surface glycoprotein CD4,23204,169,2.11 [1.56-2.86],1.354293330953632e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40,Tumor necrosis factor receptor superfamily member 5,23235,169,1.49 [1.16-1.91],0.0015416902601374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD46,Membrane cofactor protein,23155,170,1.78 [1.16-2.73],0.0080837830813269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD48,CD48 antigen,23310,169,2.84 [1.91-4.22],2.288570668727927e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5,T-cell surface glycoprotein CD5,23430,170,1.50 [1.08-2.07],0.0157053330515686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD59,CD59 glycoprotein,22455,161,2.14 [1.32-3.48],0.0021582861169138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD74,HLA class II histocompatibility antigen gamma chain,23472,168,2.41 [1.70-3.43],8.81559267025965e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD79B,B-cell antigen receptor complex-associated protein beta chain,23536,169,1.53 [1.18-1.99],0.0014339375229348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD80,T-lymphocyte activation antigen CD80,20163,130,2.56 [1.73-3.79],2.642538453829466e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD83,CD83 antigen,23240,169,2.11 [1.49-2.98],2.598272188066976e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD86,T-lymphocyte activation antigen CD86,20100,129,1.79 [1.04-3.09],0.0346042690189077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99,CD99 antigen,23278,167,2.38 [1.26-4.50],0.0078649146822924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99L2,CD99 antigen-like protein 2,23278,167,2.00 [1.16-3.44],0.0123992619585625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDCP1,CUB domain-containing protein 1,23062,169,1.54 [1.25-1.90],5.980086624331398e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH1,Cadherin-1,22512,168,1.40 [1.06-1.86],0.0195070285549662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH3,Cadherin-3,23472,168,1.55 [1.09-2.20],0.0151783176155797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19814,126,1.39 [1.03-1.88],0.0300126177624514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,23240,169,1.23 [1.06-1.43],0.0055916653428301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELA2A,Chymotrypsin-like elastase family member 2A,20171,128,0.70 [0.55-0.90],0.005196682249126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR4,Complement factor H-related protein 4,20143,128,1.41 [1.10-1.82],0.0074661889401052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGA,Glycoprotein hormones alpha chain,23278,167,1.29 [1.05-1.58],0.0159934790670325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGREF1,Cell growth regulator with EF hand domain protein 1,23267,170,1.47 [1.08-1.98],0.0132619746401677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHI3L1,Chitinase-3-like protein 1,22779,169,1.20 [1.04-1.39],0.0140061150640465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL1,Chordin-like protein 1,23310,169,2.71 [1.83-4.01],5.867307572295314e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKAP4,Cytoskeleton-associated protein 4,23424,168,1.96 [1.34-2.85],0.0004949849221521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC11A,C-type lectin domain family 11 member A,23245,167,1.42 [1.07-1.89],0.0149264615211568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC14A,C-type lectin domain family 14 member A,23278,167,1.79 [1.20-2.66],0.0041310160609027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4D,C-type lectin domain family 4 member D,23240,169,1.24 [1.00-1.53],0.0463936109349215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4G,C-type lectin domain family 4 member G,23240,169,1.69 [1.13-2.52],0.0106527004938169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC5A,C-type lectin domain family 5 member A,23192,170,1.68 [1.11-2.55],0.0144559223863999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC6A,C-type lectin domain family 6 member A,22716,165,1.59 [1.22-2.08],0.0006590937589923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC7A,C-type lectin domain family 7 member A,23536,169,1.87 [1.40-2.49],1.923315407277199e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLMP,CXADR-like membrane protein,23465,170,1.91 [1.08-3.39],0.0267880589624008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN3,Calsyntenin-3,20115,129,1.80 [1.08-2.98],0.0239981663194862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLTA,Clathrin light chain A,22843,165,1.34 [1.03-1.75],0.0319958011667815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNDP1,Beta-Ala-His dipeptidase,23375,171,0.69 [0.53-0.89],0.0047684189166565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN5,Contactin-5,23323,168,0.57 [0.39-0.84],0.0040224783428776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL18A1,Collagen alpha-1(XVIII) chain,23370,171,3.42 [2.00-5.86],7.736710346642303e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL28A1,Collagen alpha-1(XXVIII) chain,19624,123,0.67 [0.53-0.85],0.0009219800460389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A1,Collagen alpha-1(IV) chain,23267,170,1.57 [1.13-2.18],0.0065008607662953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL5A1,Collagen alpha-1(V) chain,19710,123,1.66 [1.15-2.40],0.0073814629333472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL6A3,Collagen alpha-3(VI) chain,23559,171,2.39 [1.76-3.24],1.9972452086261842e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COLEC12,Collectin-12,23227,169,2.86 [1.85-4.41],2.011684089822373e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COPB2,Coatomer subunit beta',19476,122,0.63 [0.41-0.97],0.0346779921824064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",23153,167,1.27 [1.05-1.52],0.0121561272696932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPE,Carboxypeptidase E,23274,167,0.73 [0.53-1.00],0.0495096081865574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPM,Carboxypeptidase M,23356,168,1.47 [1.00-2.16],0.0477815174355975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM2,Inactive carboxypeptidase-like protein X2,20163,130,2.42 [1.37-4.28],0.0023608676266333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CR1,Complement receptor type 1,20113,130,1.80 [1.13-2.85],0.0129473821600322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHBP,Corticotropin-releasing factor-binding protein,23227,169,2.15 [1.32-3.50],0.0021905286807141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIM1,Cysteine-rich motor neuron 1 protein,23346,169,2.59 [1.37-4.92],0.00358921399201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIP2,Cysteine-rich protein 2,23062,169,1.70 [1.32-2.18],3.978220612053142e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAC1,Cartilage acidic protein 1,23559,171,0.57 [0.37-0.86],0.0075194581482551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAM,Cytotoxic and regulatory T-cell molecule,23062,169,1.63 [1.26-2.11],0.0002196889561003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB2,Beta-crystallin B2,20115,129,1.49 [1.32-1.67],2.422530133087745e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1,Macrophage colony-stimulating factor 1,23346,169,2.54 [1.60-4.04],7.483262031524862e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1R,Macrophage colony-stimulating factor 1 receptor,20188,130,2.05 [1.47-2.87],2.4444530472486923e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST3,Cystatin-C,23331,171,2.55 [1.72-3.76],2.697958985692866e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSTB,Cystatin-B,22962,165,1.45 [1.08-1.96],0.0135373123361874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTHRC1,Collagen triple helix repeat-containing protein 1,20171,128,2.10 [1.20-3.68],0.0090475466676313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRC,Chymotrypsin-C,23228,169,0.81 [0.66-0.99],0.0429277520802549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSL,Cathepsin L1,23267,170,2.19 [1.30-3.67],0.0030194980549675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSS,Cathepsin S,18316,137,2.09 [1.06-4.10],0.032513183856513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXADR,Coxsackievirus and adenovirus receptor,23240,169,1.64 [1.28-2.09],7.046860136885474e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL10,C-X-C motif chemokine 10,23346,169,1.29 [1.08-1.55],0.0062292491077771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL13,C-X-C motif chemokine 13,23472,168,1.22 [1.03-1.46],0.0238417427740871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL16,C-X-C motif chemokine 16,23524,171,2.46 [1.42-4.24],0.0012432009975453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL9,C-X-C motif chemokine 9,23346,169,1.40 [1.18-1.67],0.0001741169530423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",23327,169,1.53 [1.05-2.22],0.0256955939027242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDI2,Protein DDI1 homolog 2,19710,123,0.71 [0.56-0.89],0.0034228349047311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDR1,Epithelial discoidin domain-containing receptor 1,23472,168,2.01 [1.17-3.46],0.011407567864239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL1,Delta-like protein 1,23327,169,1.95 [1.29-2.95],0.0014562262650007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA1,DnaJ homolog subfamily A member 1,19464,125,0.57 [0.36-0.91],0.0196064351269773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA4,DnaJ homolog subfamily A member 4,20115,129,0.75 [0.59-0.96],0.0202040408831771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOCK9,Dedicator of cytokinesis protein 9,19511,122,1.15 [1.01-1.30],0.0323597689996089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPT,Dermatopontin,23559,171,2.15 [1.22-3.78],0.0077134365905799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPY30,Protein dpy-30 homolog,23402,170,1.29 [1.06-1.58],0.0123346342850801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSC2,Desmocollin-2,22999,166,2.39 [1.68-3.40],1.2637850805826297e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG3,Desmoglein-3,23385,169,1.51 [1.04-2.20],0.0293389655146028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTX3,Probable E3 ubiquitin-protein ligase DTX3,23153,167,1.88 [1.18-3.01],0.0082617221520858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP3,Dual specificity protein phosphatase 3,22749,164,0.82 [0.68-0.99],0.0401004056796533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EBI3_IL27,Interleukin-27,23439,170,1.66 [1.08-2.56],0.0220091213283644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDA2R,Tumor necrosis factor receptor superfamily member 27,23465,170,1.99 [1.47-2.69],7.847386832331187e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,23340,171,2.05 [1.38-3.04],0.0003854742202418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA1,Ephrin-A1,23236,167,2.80 [1.92-4.08],8.757257207257973e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA4,Ephrin-A4,23021,168,2.81 [2.06-3.84],5.879179887151136e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNB2,Ephrin-B2,19624,123,1.34 [1.08-1.65],0.006878172916341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFR,Epidermal growth factor receptor,23559,171,0.37 [0.20-0.68],0.0014308212108606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELN,Elastin,20163,130,1.88 [1.18-2.99],0.0079085663780832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,23559,171,1.83 [1.09-3.08],0.0222040636773309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19613,127,0.61 [0.38-0.98],0.0404216064180194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22716,165,1.39 [1.02-1.90],0.0365524333036622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA2,Ephrin type-A receptor 2,22399,163,2.48 [1.74-3.53],4.624437497399186e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB4,Ephrin type-B receptor 4,23559,171,2.75 [1.75-4.33],1.2362099837777832e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB6,Ephrin type-B receptor 6,23029,169,1.77 [1.20-2.63],0.0042411082123023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESAM,Endothelial cell-selective adhesion molecule,23559,171,1.52 [1.02-2.25],0.0374405535781285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11,Coagulation factor XI,19895,126,1.48 [1.03-2.14],0.0359366597782888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP1,"Fatty acid-binding protein, liver",23227,169,1.31 [1.15-1.49],6.034560223832808e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP2,"Fatty acid-binding protein, intestinal",23267,170,1.25 [1.07-1.46],0.0055101178418651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP3,"Fatty acid-binding protein, heart",20163,130,1.49 [1.14-1.94],0.0033645707692415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP4,"Fatty acid-binding protein, adipocyte",23559,171,1.64 [1.30-2.08],4.0267191717085e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP6,Gastrotropin,22810,164,1.39 [1.13-1.72],0.0018923649187035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3B,Protein FAM3B,23153,167,1.85 [1.24-2.75],0.0024890887200855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3C,Protein FAM3C,23237,170,2.33 [1.55-3.49],4.213703144287042e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAS,Tumor necrosis factor receptor superfamily member 6,23483,171,1.50 [1.14-1.98],0.0036286196344346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL2,Fc receptor-like protein 2,23426,168,1.45 [1.15-1.82],0.0014839536879825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF21,Fibroblast growth factor 21,23439,170,1.13 [1.02-1.26],0.0209138254073176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF23,Fibroblast growth factor 23,23424,170,1.41 [1.16-1.71],0.0006169046748021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF5,Fibroblast growth factor 5,22853,166,1.92 [1.35-2.72],0.0002811698835708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF9,Fibroblast growth factor 9,19430,125,0.57 [0.38-0.86],0.0075529241264454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP1,Fibroblast growth factor-binding protein 1,23327,169,0.58 [0.39-0.86],0.0067142796207216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR2,Fibroblast growth factor receptor 2,23327,169,1.95 [1.11-3.42],0.0202180463030942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGL1,Fibrinogen-like protein 1,20188,130,1.55 [1.22-1.97],0.0003902812987048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,23062,169,2.61 [1.71-4.01],1.0313286182663965e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR1,Folate receptor alpha,23228,167,1.71 [1.13-2.59],0.0117403400593549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR2,Folate receptor beta,23472,168,2.25 [1.44-3.49],0.000334123743199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL3,Follistatin-related protein 3,23195,168,2.43 [1.71-3.45],8.030196214941276e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FZD10,Frizzled-10,19624,123,1.30 [1.06-1.58],0.0106134823642213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,23153,167,1.67 [1.03-2.70],0.0369830654505232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,23465,170,0.58 [0.35-0.95],0.0318620945934388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS6,Growth arrest-specific protein 6,23416,171,2.25 [1.32-3.84],0.0029351504949047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAST,Gastrin,20115,129,1.16 [1.04-1.30],0.0068241491938419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP4,Guanylate-binding protein 4,22749,164,1.63 [1.30-2.03],1.842942873438216e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",23153,167,2.00 [1.37-2.92],0.0003442326137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF15,Growth/differentiation factor 15,23559,171,2.06 [1.66-2.55],3.738353260766097e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFAP,Glial fibrillary acidic protein,22678,165,1.46 [1.11-1.92],0.0061636078243136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA1,GDNF family receptor alpha-1,23439,170,2.70 [1.78-4.08],2.7186686077163032e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA3,GDNF family receptor alpha-3,22990,169,1.75 [1.09-2.80],0.0201957378695739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT1,Glutathione hydrolase 1 proenzyme,23236,167,1.41 [1.11-1.79],0.0050802605168838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT5,Glutathione hydrolase 5 proenzyme,23062,169,1.97 [1.15-3.35],0.0127997702797668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHR,Growth hormone receptor,19710,123,0.32 [0.17-0.58],0.0001984643188078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHRL,Appetite-regulating hormone,23267,170,0.83 [0.71-0.98],0.0254010769740389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLRX,Glutaredoxin-1,23119,168,0.74 [0.58-0.95],0.0187051168189531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GM2A,Ganglioside GM2 activator,19681,125,1.42 [1.00-2.02],0.0487579060341923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPKOW,G-patch domain and KOW motifs-containing protein,22749,164,1.43 [1.03-1.99],0.0305889956795169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPNMB,Transmembrane glycoprotein NMB,22637,166,2.27 [1.42-3.62],0.0005716757226894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR15L,Protein GPR15L,20100,129,1.49 [1.16-1.91],0.0019781859177997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR37,Prosaposin receptor GPR37,22843,165,1.55 [1.26-1.91],3.4700779028227435e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPRC5C,G-protein coupled receptor family C group 5 member C,20093,131,1.44 [1.15-1.80],0.0012792266635336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRN,Progranulin,23153,166,2.09 [1.25-3.49],0.0047395824769762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRPEL1,"GrpE protein homolog 1, mitochondrial",23153,167,1.38 [1.13-1.69],0.0017189081901945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCA2A,Guanylin,23157,166,2.12 [1.50-2.99],1.8929595204347463e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMA,Granzyme A,23536,169,1.46 [1.00-2.13],0.0479256352260843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",23404,170,0.80 [0.66-0.98],0.0283408298941718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR1,Hepatitis A virus cellular receptor 1,23430,170,1.41 [1.17-1.71],0.0003093263280965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR2,Hepatitis A virus cellular receptor 2,23278,167,2.56 [1.86-3.51],6.032612928261888e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBQ1,Hemoglobin subunit theta-1,23465,170,0.71 [0.56-0.89],0.0035467083543085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HCG22,Protein PBMUCL2,19476,122,0.59 [0.36-0.97],0.0359787853675405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPACAM2,HEPACAM family member 2,20115,129,0.66 [0.45-0.97],0.0359579141183078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGF,Hepatocyte growth factor,23536,169,1.54 [1.07-2.23],0.020153059216438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",23163,169,1.80 [1.27-2.53],0.0008620873213958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-E,"HLA class I histocompatibility antigen, alpha chain E",23240,169,2.15 [1.45-3.20],0.0001368540711293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMBS,Porphobilinogen deaminase,23465,170,0.68 [0.49-0.94],0.0212157769866543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX2,Heme oxygenase 2,22749,164,1.31 [1.02-1.69],0.0336407538349924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNMT,Histamine N-methyltransferase,22958,168,1.63 [1.24-2.13],0.0003970884588863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPGDS,Hematopoietic prostaglandin D synthase,22716,165,0.67 [0.46-0.98],0.0396296439180653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB6,Heat shock protein beta-6,23465,170,1.70 [1.26-2.30],0.0005747019197115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23112,170,2.18 [1.45-3.29],0.0001986320259975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYAL1,Hyaluronidase-1,23167,170,2.15 [1.24-3.71],0.0060133323485467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYOU1,Hypoxia up-regulated protein 1,23559,171,1.91 [1.09-3.35],0.0246552111871429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM1,Intercellular adhesion molecule 1,23182,170,1.83 [1.18-2.83],0.0068228201371803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM3,Intercellular adhesion molecule 3,23559,171,2.17 [1.38-3.43],0.0008609514856038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDI2,Isopentenyl-diphosphate delta-isomerase 2,22749,164,1.54 [1.21-1.96],0.0004562404806663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19621,128,1.73 [1.18-2.53],0.0050967113523655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR1,Interferon gamma receptor 1,23346,169,2.35 [1.49-3.71],0.000237666416502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL1,Interferon lambda-1,22749,164,1.43 [1.09-1.88],0.0091210934036725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,20171,128,0.57 [0.32-0.99],0.0474756002866867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF1R,Insulin-like growth factor 1 receptor,23153,167,2.15 [1.23-3.73],0.0067625349019502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP2,Insulin-like growth factor-binding protein 2,23524,171,1.48 [1.19-1.84],0.0005168871218302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP3,Insulin-like growth factor-binding protein 3,23375,171,0.62 [0.43-0.89],0.0094753543803409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP4,Insulin-like growth factor-binding protein 4,23002,166,1.69 [1.31-2.17],4.632105413442875e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP6,Insulin-like growth factor-binding protein 6,23187,170,1.67 [1.15-2.43],0.0067263325870286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP7,Insulin-like growth factor-binding protein 7,23559,171,1.65 [1.17-2.34],0.004342138148452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBPL1,Insulin-like growth factor-binding protein-like 1,23267,170,1.54 [1.07-2.23],0.0215339268820486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLC2,Immunoglobulin lambda constant 2,20158,128,1.68 [1.11-2.52],0.0131408686914801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF8,Immunoglobulin superfamily member 8,23267,170,1.80 [1.23-2.63],0.002465746032803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RB,Interleukin-10 receptor subunit beta,23346,169,2.33 [1.68-3.21],3.0057406466293496e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12A_IL12B,Interleukin-12,23153,167,1.32 [1.12-1.56],0.0011115979631465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12B,Interleukin-12 subunit beta,23536,169,1.36 [1.07-1.74],0.0118995458107325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB1,Interleukin-12 receptor subunit beta-1,22853,166,1.85 [1.30-2.62],0.0005927711412801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15RA,Interleukin-15 receptor subunit alpha,22853,166,2.04 [1.39-2.99],0.0002523819269409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17C,Interleukin-17C,22853,166,1.42 [1.22-1.65],5.912140290248685e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18,Interleukin-18,23148,169,1.66 [1.26-2.18],0.0003586310424435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18BP,Interleukin-18-binding protein,23375,171,2.18 [1.49-3.19],6.44093577393186e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18R1,Interleukin-18 receptor 1,23536,169,1.70 [1.14-2.53],0.0088273859666033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL19,Interleukin-19,22688,168,1.36 [1.16-1.59],0.0001162980667965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1R1,Interleukin-1 receptor type 1,23236,167,1.75 [1.00-3.04],0.0484694221650584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL1,Interleukin-1 receptor-like 1,23483,171,1.57 [1.17-2.10],0.0026311369316731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RN,Interleukin-1 receptor antagonist protein,23189,169,1.36 [1.10-1.68],0.0048656139985985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22,Interleukin-22,20093,131,1.44 [1.18-1.77],0.0004406737966397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RA,Interleukin-2 receptor subunit alpha,23121,166,1.89 [1.46-2.46],1.5826071831957688e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RG,Cytokine receptor common subunit gamma,20093,131,1.61 [1.16-2.24],0.0047222235685735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4R,Interleukin-4 receptor subunit alpha,23240,169,1.79 [1.29-2.49],0.0005240517394174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6,Interleukin-6,23153,167,1.20 [1.03-1.39],0.0177369823287097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6ST,Interleukin-6 receptor subunit beta,23267,170,2.39 [1.14-5.00],0.0205451533367276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBB,Inhibin beta B chain,19710,123,1.48 [1.09-2.01],0.0122919533476788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL3,Insulin-like 3,20115,129,0.80 [0.67-0.96],0.0163511375167323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL5,Insulin-like peptide INSL5,20100,129,1.27 [1.09-1.48],0.0026032720694192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA11,Integrin alpha-11,23240,169,0.62 [0.42-0.93],0.0197025723770606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA5,Integrin alpha-5,23278,167,1.96 [1.16-3.34],0.0125806734707928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAV,Integrin alpha-V,23465,170,0.48 [0.26-0.87],0.0161365140596381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB7,Integrin beta-7,23465,170,1.41 [1.07-1.86],0.0135520290588506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,23375,171,1.87 [1.31-2.67],0.0005427329754771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22749,164,1.27 [1.00-1.61],0.0496665574595499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM2,Junctional adhesion molecule B,23472,168,1.72 [1.08-2.75],0.0215760401581367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JUN,Transcription factor AP-1,22853,166,1.33 [1.07-1.64],0.0088601631299003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22716,165,1.27 [1.07-1.51],0.0057527580863735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIRREL1,Kin of IRRE-like protein 1,19511,122,1.31 [1.05-1.64],0.016184049363511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK10,Kallikrein-10,23263,169,1.49 [1.11-1.98],0.0069234978695682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK11,Kallikrein-11,23108,169,1.79 [1.35-2.36],4.125597484749375e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK4,Kallikrein-4,23465,170,1.54 [1.30-1.83],6.097964113655998e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK8,Kallikrein-8,22477,164,1.62 [1.14-2.30],0.0071725133238003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRB1,Killer cell lectin-like receptor subfamily B member 1,23536,169,2.04 [1.48-2.81],1.274288969626044e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRD1,Natural killer cells antigen CD94,23536,169,1.58 [1.19-2.09],0.0015104784930671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT19,"Keratin, type I cytoskeletal 19",23197,169,1.24 [1.03-1.50],0.0233214579136603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT5,"Keratin, type II cytoskeletal 5",22749,164,1.33 [1.04-1.69],0.0223456785546256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAG3,Lymphocyte activation gene 3 protein,23153,167,1.45 [1.08-1.95],0.0138247124060174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,23227,169,1.95 [1.54-2.48],3.374034421575212e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA4,Laminin subunit alpha-4,23346,169,1.61 [1.10-2.35],0.0134119711059922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP3,Lysosome-associated membrane glycoprotein 3,23498,168,1.38 [1.07-1.77],0.0124804363293443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAYN,Layilin,23029,169,2.21 [1.61-3.03],7.856843256607303e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBP,Lipopolysaccharide-binding protein,23375,171,1.42 [1.14-1.79],0.002279948795823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCAT,Phosphatidylcholine-sterol acyltransferase,20188,130,0.40 [0.19-0.85],0.0165060238298236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LECT2,Leukocyte cell-derived chemotaxin-2,20163,130,1.31 [1.03-1.67],0.0266604918650494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEP,Leptin,23267,170,1.22 [1.00-1.49],0.0497890427508382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS1,Galectin-1,23267,170,1.57 [1.10-2.24],0.0126021385186051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS3,Galectin-3,23341,170,1.62 [1.04-2.52],0.0340276540873665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS4,Galectin-4,23227,169,1.61 [1.29-1.99],1.739695403835178e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS7_LGALS7B,Galectin-7,23200,170,1.40 [1.07-1.82],0.0140447935447151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS9,Galectin-9,23235,169,2.83 [1.93-4.14],9.493524507955972e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,23278,167,1.99 [1.33-2.97],0.0007791370871187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,23237,170,2.04 [1.36-3.05],0.0005445115925879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,23448,171,1.80 [1.20-2.70],0.0046122340107537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22853,166,1.99 [1.50-2.64],1.72428635704682e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIPF,Gastric triacylglycerol lipase,19613,127,0.76 [0.57-1.00],0.048606984383936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,23404,170,1.58 [1.09-2.29],0.0158136532853102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP11,Low-density lipoprotein receptor-related protein 11,23267,170,1.65 [1.16-2.34],0.0049301350564666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC25,Leucine-rich repeat-containing protein 25,23153,167,1.51 [1.11-2.04],0.0076730033287528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP2,Latent-transforming growth factor beta-binding protein 2,23559,171,1.91 [1.28-2.86],0.0015017634795264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBR,Tumor necrosis factor receptor superfamily member 3,23107,169,2.31 [1.56-3.41],2.782543755139289e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY6D,Lymphocyte antigen 6D,23115,168,1.70 [1.28-2.26],0.0002285300097576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY9,T-lymphocyte surface antigen Ly-9,22973,164,1.97 [1.28-3.03],0.0020184855992022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY96,Lymphocyte antigen 96,23062,169,1.85 [1.36-2.52],8.7888907828869e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYZL2,Lysozyme-like protein 2,19464,125,1.57 [1.08-2.30],0.0186376374198369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22989,169,1.30 [1.06-1.59],0.0101889157510354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAG,Myelin-associated glycoprotein,19624,123,0.66 [0.48-0.92],0.0126983988620559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MARCO,Macrophage receptor MARCO,23267,170,2.21 [1.31-3.73],0.0029108187142266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN2,Matrilin-2,23263,169,2.40 [1.54-3.74],0.0001151288298353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MB,Myoglobin,23559,171,1.28 [1.03-1.60],0.0266204571991031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDK,Midkine,23249,168,1.35 [1.07-1.71],0.0107365726712664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1B,Meprin A subunit beta,23267,170,0.88 [0.78-0.98],0.0213149094408655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MERTK,Tyrosine-protein kinase Mer,23536,169,2.15 [1.26-3.66],0.0047086184624891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MIA,Melanoma-derived growth regulatory protein,23327,169,1.47 [1.05-2.05],0.026061011769245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MILR1,Allergin-1,22853,166,1.40 [1.08-1.80],0.0099972410619987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MME,Neprilysin,23153,167,1.23 [1.04-1.45],0.0149877533983651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP10,Stromelysin-2,23185,169,1.40 [1.13-1.72],0.0020926052561711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP12,Macrophage metalloelastase,23297,169,1.60 [1.27-2.01],5.191289150938502e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP13,Collagenase 3,22749,164,1.73 [1.12-2.65],0.0129219786880912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP7,Matrilysin,22811,165,1.36 [1.02-1.82],0.0342970333051074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRC1,Macrophage mannose receptor 1,20188,130,3.28 [1.92-5.60],1.3798950485630453e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRI1,Methylthioribose-1-phosphate isomerase,19624,123,0.77 [0.60-0.98],0.0346939067943478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSLN,Mesothelin,23113,167,1.30 [1.05-1.62],0.0152960211792167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSR1,Macrophage scavenger receptor types I and II,23472,168,1.74 [1.32-2.31],0.0001049454733288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC13,Mucin-13,22749,164,1.29 [1.00-1.67],0.0492670798839798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC1,"Myosin-binding protein C, slow-type",20163,130,1.26 [1.03-1.53],0.0250051385560033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM1,Myomesin-1,19511,122,1.37 [1.06-1.77],0.0170813549519689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM2,Myomesin-2,19476,122,1.41 [1.10-1.81],0.007558617068573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZB1,Marginal zone B- and B1-cell-specific protein,23299,169,1.43 [1.11-1.83],0.0050004926572046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBL1,Neuroblastoma suppressor of tumorigenicity 1,23327,169,2.28 [1.44-3.61],0.000447138325805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM2,Neural cell adhesion molecule 2,23278,167,0.51 [0.31-0.85],0.0104612406074703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAN,Neurocan core protein,23472,168,0.60 [0.42-0.85],0.0036895618100959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR1,Natural cytotoxicity triggering receptor 1,23207,166,1.46 [1.03-2.08],0.0319183189456138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN2,Nectin-2,23237,170,2.03 [1.37-3.01],0.0003951442789545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN4,Nectin-4,23327,169,1.74 [1.24-2.45],0.0013068197267994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEFL,Neurofilament light polypeptide,22681,163,1.88 [1.52-2.32],4.732691516886663e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFASC,Neurofascin,23536,169,1.58 [1.01-2.47],0.0441135890672578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGFR,Tumor necrosis factor receptor superfamily member 16,20163,130,1.50 [1.01-2.24],0.0459588072802652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NIT1,Deaminated glutathione amidase,19613,127,0.67 [0.47-0.96],0.0299330354103589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS1,"Nitric oxide synthase, brain",22749,164,1.49 [1.21-1.83],0.0001747975929649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPC2,NPC intracellular cholesterol transporter 2,19830,127,1.88 [1.24-2.85],0.0028217760757483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPDC1,Neural proliferation differentiation and control protein 1,23267,170,2.08 [1.53-2.82],3.094252770702082e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPHS2,Podocin,19566,122,1.18 [1.03-1.37],0.0192497815940158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRP1,Neuropilin-1,23413,171,1.73 [1.06-2.83],0.0274368435865886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C1A,Cytosolic 5'-nucleotidase 1A,20115,129,1.52 [1.01-2.28],0.0462757662838003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTproBNP,N-terminal prohormone of brain natriuretic peptide,23267,170,1.17 [1.05-1.31],0.0053905580446087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUCB2,Nucleobindin-2,23431,170,1.64 [1.17-2.32],0.0044420775774003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUP50,Nuclear pore complex protein Nup50,19476,122,0.47 [0.23-0.95],0.0365191504081128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OCLN,Occludin,20124,129,1.77 [1.27-2.46],0.0006820638448326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGN,Mimecan,23278,167,2.05 [1.55-2.70],4.67801868420571e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSCAR,Osteoclast-associated immunoglobulin-like receptor,23263,169,2.02 [1.37-3.00],0.0004115482946575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSMR,Oncostatin-M-specific receptor subunit beta,23413,171,2.17 [1.11-4.26],0.0243710839042326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,20124,129,1.15 [1.02-1.30],0.0232745117293014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19814,126,1.41 [1.05-1.88],0.0221483707046498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAK4,Serine/threonine-protein kinase PAK 4,22749,164,1.23 [1.00-1.51],0.0467551110652508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM2,Paralemmin-2,20115,129,1.51 [1.01-2.25],0.0435148840672929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK7,Proprotein convertase subtilisin/kexin type 7,20093,131,1.42 [1.10-1.83],0.0071588620966856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK9,Proprotein convertase subtilisin/kexin type 9,23559,171,1.42 [1.02-1.98],0.0402181351312866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1,Programmed cell death protein 1,23421,170,1.39 [1.03-1.88],0.0310364407030559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1LG2,Programmed cell death 1 ligand 2,23153,167,1.72 [1.15-2.57],0.0085969812053711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22716,165,1.32 [1.07-1.63],0.0093834893455833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19566,122,1.50 [1.08-2.06],0.0141599130599005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGF,Placenta growth factor,23536,169,2.31 [1.58-3.39],1.7574431564210998e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,23062,169,2.05 [1.30-3.22],0.0019330064004933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI3,Elafin,22970,167,1.43 [1.16-1.77],0.0007367120670389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIGR,Polymeric immunoglobulin receptor,22974,165,1.89 [1.34-2.66],0.0002514107884162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,23278,167,2.37 [1.61-3.48],1.1650600489663616e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRA,Paired immunoglobulin-like type 2 receptor alpha,23278,167,2.16 [1.57-2.97],2.335193028448871e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRB,Paired immunoglobulin-like type 2 receptor beta,23267,170,1.75 [1.35-2.26],2.0638735017746687e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G15,Phospholipase A2 group XV,23327,169,1.86 [1.17-2.96],0.0090172589674633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G2A,"Phospholipase A2, membrane associated",23251,164,1.25 [1.01-1.55],0.0414543301341851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G7,Platelet-activating factor acetylhydrolase,23278,167,0.61 [0.41-0.91],0.0141176602043686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAUR,Urokinase plasminogen activator surface receptor,23073,169,3.12 [2.06-4.73],8.110007976142903e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLB1,"Phospholipase B1, membrane-associated",20115,129,0.74 [0.56-0.98],0.0336175997069964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB2,Plexin-B2,23445,171,2.38 [1.45-3.92],0.0006585916189157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIP,Pancreatic triacylglycerol lipase,20188,130,0.74 [0.58-0.95],0.0199002766672601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",23153,167,1.43 [1.07-1.90],0.0150427662990995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON1,Serum paraoxonase/arylesterase 1,20188,130,0.52 [0.31-0.90],0.0180673617943913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON3,Serum paraoxonase/lactonase 3,23346,169,0.70 [0.50-0.98],0.0371623356831148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP3R1,Calcineurin subunit B type 1,23062,169,1.60 [1.16-2.22],0.0040413812251449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX2,Peroxiredoxin-2,19846,128,0.67 [0.50-0.90],0.0073450396178637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PREB,Prolactin regulatory element-binding protein,22853,166,1.89 [1.33-2.69],0.0003597800811023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRELP,Prolargin,23227,169,2.19 [1.22-3.95],0.0090590968226565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRL,Prolactin,23472,168,1.27 [1.07-1.50],0.0053651375487317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROS1,Vitamin K-dependent protein S,20185,128,0.40 [0.22-0.75],0.0043749039637153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS8,Prostasin,23153,169,1.56 [1.14-2.12],0.0049162490387436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAP,Prosaposin,19984,127,1.69 [1.01-2.83],0.0454995096921195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSG1,Pregnancy-specific beta-1-glycoprotein 1,23062,169,1.25 [1.08-1.43],0.0020440765904369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSRC1,Proline/serine-rich coiled-coil protein 1,22716,165,1.35 [1.11-1.65],0.0029975126785056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGDS,Prostaglandin-H2 D-isomerase,23112,170,2.06 [1.46-2.92],4.54123020338046e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,23240,169,1.37 [1.04-1.79],0.0227089908208088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTK7,Inactive tyrosine-protein kinase 7,22749,164,1.47 [1.02-2.12],0.0387732463870171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTN,Pleiotrophin,22843,165,1.42 [1.09-1.84],0.0085504089511551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRC,Receptor-type tyrosine-protein phosphatase C,20171,128,2.18 [1.16-4.09],0.0155635338162066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22988,169,1.78 [1.22-2.60],0.0025716713713596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QPCT,Glutaminyl-peptide cyclotransferase,23287,167,2.18 [1.34-3.55],0.001628400056254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES2,Retinoic acid receptor responder protein 2,23413,171,1.44 [1.13-1.82],0.002944546443647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASA1,Ras GTPase-activating protein 1,22749,164,1.51 [1.06-2.15],0.0222853909353749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19464,125,0.65 [0.43-0.99],0.0444531081172582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBFOX3,RNA binding protein fox-1 homolog 3,20124,129,1.76 [1.31-2.38],0.0002096324431473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBKS,Ribokinase,22718,166,0.75 [0.59-0.95],0.0176901986686116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM19,Probable RNA-binding protein 19,19476,122,0.61 [0.37-0.99],0.04401741044093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP2,Retinol-binding protein 2,23153,167,1.27 [1.07-1.50],0.0058443812547972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP5,Retinol-binding protein 5,23153,167,1.33 [1.05-1.68],0.0158476894000401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1A,Lithostathine-1-alpha,23148,170,1.59 [1.27-1.99],4.951340887577055e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1B,Lithostathine-1-beta,23559,171,1.47 [1.20-1.79],0.0001540759995651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3A,Regenerating islet-derived protein 3-alpha,23559,171,1.46 [1.22-1.76],5.374153362737629e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG4,Regenerating islet-derived protein 4,23263,169,1.67 [1.31-2.12],2.9494028165155933e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELT,Tumor necrosis factor receptor superfamily member 19L,23278,167,2.27 [1.53-3.37],4.259587895693196e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REN,Renin,23267,170,1.34 [1.16-1.54],5.382897962931476e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RETN,Resistin,23223,170,1.38 [1.03-1.84],0.0289286567767393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE1,Ribonuclease pancreatic,20188,130,2.04 [1.22-3.41],0.0066458748402752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE6,Ribonuclease K6,20053,130,1.81 [1.36-2.40],4.9897434642816814e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASET2,Ribonuclease T2,23447,169,2.19 [1.38-3.46],0.0008310822722265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF149,E3 ubiquitin-protein ligase RNF149,19613,127,1.68 [1.02-2.78],0.0429942754577487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO1,Roundabout homolog 1,23263,169,2.19 [1.30-3.68],0.0032483503265885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,23267,170,1.54 [1.02-2.32],0.0400628041840922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO3,R-spondin-3,23465,170,2.13 [1.39-3.27],0.0005625095403625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A4,Protein S100-A4,23327,169,0.74 [0.58-0.94],0.0133851020597176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARA5,Scavenger receptor class A member 5,23472,168,2.48 [1.63-3.77],2.0384887072885e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB1,Scavenger receptor class B member 1,22749,164,1.28 [1.06-1.55],0.0109532651044239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB2,Lysosome membrane protein 2,22603,168,2.34 [1.70-3.22],1.8318801245366066e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF2,Scavenger receptor class F member 2,23472,168,2.10 [1.33-3.30],0.0013969364486474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG2,Secretogranin-2,23370,170,1.50 [1.01-2.22],0.0453907942595139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGN,Secretagogin,22853,166,1.36 [1.02-1.81],0.036685370893628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC1,Syndecan-1,23267,170,1.39 [1.01-1.92],0.0432562410751641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDHB,Succinate dehydrogenase,20100,129,1.26 [1.00-1.59],0.0467093552350955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELENOP,Selenoprotein P,20185,128,0.47 [0.27-0.83],0.0087650218034165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA3F,Semaphorin-3F,23267,170,1.70 [1.04-2.80],0.0358377234880717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP1,Secreted frizzled-related protein 1,22980,168,1.58 [1.22-2.05],0.0005283882429613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19511,122,1.27 [1.03-1.58],0.0277132006734137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHISA5,Protein shisa-5,20171,128,1.78 [1.10-2.87],0.0184774877454128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC1,Sialoadhesin,23346,169,2.10 [1.57-2.80],4.621053487853609e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC10,Sialic acid-binding Ig-like lectin 10,23240,169,1.70 [1.22-2.38],0.0019656245615965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC5,Sialic acid-binding Ig-like lectin 5,23278,167,1.30 [1.12-1.51],0.0007109327714099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC7,Sialic acid-binding Ig-like lectin 7,23267,170,2.03 [1.28-3.23],0.002835606365996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC8,Sialic acid-binding Ig-like lectin 8,19613,127,1.44 [1.01-2.07],0.0453863797935003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC9,Sialic acid-binding Ig-like lectin 9,23430,170,1.89 [1.21-2.94],0.0050719715469413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,23333,171,1.30 [1.01-1.67],0.0421718955637141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPB1,Signal-regulatory protein beta-1,23182,169,1.52 [1.15-2.00],0.0029488206766876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF1,Signaling lymphocytic activation molecule,22853,166,1.37 [1.09-1.73],0.0074073126372137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF7,SLAM family member 7,23240,169,1.37 [1.11-1.70],0.0039574761023996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF8,SLAM family member 8,22716,165,1.43 [1.10-1.87],0.0076427380126079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC16A1,Monocarboxylate transporter 1,22749,164,1.31 [1.06-1.61],0.0107569114504958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC27A4,Long-chain fatty acid transport protein 4,22749,164,1.29 [1.09-1.52],0.002681666482085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A14,Zinc transporter ZIP14,22749,164,1.53 [1.10-2.15],0.012789181862786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC4A1,Band 3 anion transport protein,20171,128,0.67 [0.46-0.97],0.0333728888089676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORCS2,VPS10 domain-containing receptor SorCS2,22716,165,2.05 [1.47-2.87],2.705539201904873e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK1,Serine protease inhibitor Kazal-type 1,23278,167,1.71 [1.28-2.27],0.000223829023474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK6,Serine protease inhibitor Kazal-type 6,23465,170,1.46 [1.12-1.90],0.0048356247051653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT1,Kunitz-type protease inhibitor 1,23190,167,2.16 [1.39-3.36],0.0006084507975147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON1,Spondin-1,23263,169,1.88 [1.34-2.66],0.0003113565631735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON2,Spondin-2,23156,170,2.57 [1.79-3.68],2.8890564872911664e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPP1,Osteopontin,23524,171,1.50 [1.12-2.00],0.006264214073115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPX,Sushi repeat-containing protein SRPX,20163,130,1.84 [1.18-2.87],0.0070914187884601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23559,171,1.83 [1.30-2.58],0.0005044379010136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC1,Stanniocalcin-1,23472,168,1.33 [1.01-1.75],0.0449148518813945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAFA5,Chemokine-like protein TAFA-5,23153,167,1.96 [1.42-2.71],4.201811525466447e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN2,Transcobalamin-2,23524,171,1.95 [1.34-2.85],0.0005414584683443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDRKH,Tudor and KH domain-containing protein,22749,164,1.20 [1.03-1.40],0.0207054535754896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TET2,Methylcytosine dioxygenase TET2,19778,126,1.21 [1.07-1.37],0.0023719756779456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF1,Trefoil factor 1,23166,166,1.24 [1.07-1.45],0.0053303178534376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF2,Trefoil factor 2,23310,169,1.41 [1.14-1.75],0.0015452392927151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF3,Trefoil factor 3,23259,170,1.67 [1.35-2.06],2.396063065309094e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFA,Protransforming growth factor alpha,23240,169,1.69 [1.31-2.18],5.478713016969592e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR2,TGF-beta receptor type-2,23327,169,1.68 [1.20-2.34],0.0024980179109002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR3,Transforming growth factor beta receptor type 3,23559,171,1.61 [1.04-2.51],0.0333103612586763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBD,Thrombomodulin,23267,170,1.67 [1.10-2.54],0.015949007928201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS2,Thrombospondin-2,23278,167,1.52 [1.11-2.09],0.0097669058579345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THRAP3,Thyroid hormone receptor-associated protein 3,19476,122,1.20 [1.06-1.36],0.0050312816152313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THY1,Thy-1 membrane glycoprotein,23472,168,1.95 [1.25-3.04],0.0032557199226979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP1,Metalloproteinase inhibitor 1,23037,169,1.75 [1.14-2.69],0.0101374126774956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP4,Metalloproteinase inhibitor 4,23278,167,1.70 [1.25-2.31],0.0006871113326633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TINAGL1,Tubulointerstitial nephritis antigen-like,23201,170,1.92 [1.05-3.51],0.0335310899126949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR1,Toll-like receptor 1,19566,122,2.05 [1.15-3.68],0.0157258166244411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR2,Toll-like receptor 2,19814,126,2.15 [1.15-4.01],0.0162814209802595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED1,Transmembrane emp24 domain-containing protein 1,19814,126,0.56 [0.39-0.82],0.0030808015703273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED4,Transmembrane emp24 domain-containing protein 4,19476,122,0.66 [0.44-0.99],0.046092330019848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS5,Transmembrane protease serine 5,22949,167,1.87 [1.32-2.66],0.0004723427812654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMSB10,Thymosin beta-10,23278,167,1.22 [1.02-1.46],0.0270897428005323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNF,Tumor necrosis factor,22811,164,1.49 [1.14-1.96],0.00374933283974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,23062,169,1.92 [1.42-2.60],2.2772986895911348e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,23062,169,1.36 [1.16-1.60],0.0002044554214013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23536,169,2.00 [1.50-2.68],3.002993425937958e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,23227,169,2.02 [1.33-3.07],0.0010170488348133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,23327,169,2.00 [1.45-2.76],2.819694739190365e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,23263,169,1.83 [1.42-2.35],2.940375987921701e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,23263,169,2.31 [1.60-3.33],8.057694648738202e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,23465,170,2.09 [1.52-2.88],6.503027616670147e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,23278,167,2.73 [1.92-3.88],2.283974369562565e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,23278,167,1.78 [1.46-2.17],1.2086271490466783e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,23472,168,1.89 [1.21-2.97],0.0052230404829259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23498,168,2.02 [1.49-2.73],5.698678206185693e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,23062,169,1.62 [1.34-1.96],8.282814695706891e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,23472,168,1.36 [1.03-1.81],0.0325205387221164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,23062,169,1.73 [1.38-2.15],1.4940161761081007e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF12,Tumor necrosis factor ligand superfamily member 12,23536,169,0.58 [0.35-0.94],0.0257336455963449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13,Tumor necrosis factor ligand superfamily member 13,23346,169,2.53 [1.60-4.01],7.505586389539338e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23524,171,2.21 [1.46-3.34],0.0001604491474882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF8,Tumor necrosis factor ligand superfamily member 8,20171,128,1.86 [1.23-2.82],0.0034015098199436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNIP1,TNFAIP3-interacting protein 1,20115,129,0.82 [0.67-1.00],0.0452232997770719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPMT,Thiopurine S-methyltransferase,22716,165,0.81 [0.66-0.99],0.037107934517847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSAB1,Tryptase alpha/beta-1,23498,169,1.36 [1.05-1.77],0.0213534805676312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREM2,Triggering receptor expressed on myeloid cells 2,23227,169,1.44 [1.14-1.83],0.0021164297797546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML2,Trem-like transcript 2 protein,23278,167,1.85 [1.29-2.64],0.0007556564012281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIAP1,TP53-regulated inhibitor of apoptosis 1,23465,170,1.25 [1.01-1.55],0.0372647570835765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRPV3,Transient receptor potential cation channel subfamily V member 3,19476,122,0.62 [0.41-0.96],0.0299334717371705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSC1,Hamartin,19566,122,0.54 [0.37-0.80],0.0020415918793338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN8,Tetraspanin-8,20100,129,1.23 [1.03-1.46],0.0227933850551832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTR,Transthyretin,19970,127,0.49 [0.26-0.94],0.0328026585311237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC5,Thioredoxin domain-containing protein 5,23472,168,1.28 [1.06-1.55],0.011597034975908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UGDH,UDP-glucose 6-dehydrogenase,19476,122,1.16 [1.01-1.34],0.0365725525759334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ULBP2,UL16-binding protein 2,23062,169,1.84 [1.34-2.52],0.0001414259322579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UMOD,Uromodulin,23478,171,0.71 [0.57-0.90],0.0042757020881375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UROS,Uroporphyrinogen-III synthase,19624,123,0.74 [0.55-0.99],0.0428040845377337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAMP5,Vesicle-associated membrane protein 5,22843,165,1.33 [1.08-1.63],0.0071683626033157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAM1,Vascular cell adhesion protein 1,23341,171,2.18 [1.39-3.41],0.0006924777096373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAN,Versican core protein,23472,168,1.88 [1.22-2.90],0.0045167728410446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10,V-set and immunoglobulin domain-containing protein 10,20093,131,1.49 [1.03-2.17],0.0360387684572917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG2,V-set and immunoglobulin domain-containing protein 2,20093,131,1.32 [1.04-1.66],0.0206088035819605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG4,V-set and immunoglobulin domain-containing protein 4,23248,167,2.93 [2.26-3.82],9.91802248892269e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM1,V-set and transmembrane domain-containing protein 1,22749,164,1.31 [1.03-1.68],0.0302229410737678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTCN1,V-set domain-containing T-cell activation inhibitor 1,22716,165,1.61 [1.08-2.41],0.0194915049379166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA1,von Willebrand factor A domain-containing protein 1,23439,170,1.52 [1.11-2.08],0.0083912930182016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2,Brorin,22988,168,2.16 [1.57-2.97],2.3314857850810484e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC2,WAP four-disulfide core domain protein 2,22096,160,2.08 [1.60-2.70],3.188639739652933e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22978,168,0.66 [0.47-0.93],0.0166791515944163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WNT9A,Protein Wnt-9a,22853,166,2.39 [1.68-3.42],1.5919743109260191e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XCL1,Lymphotactin,23465,170,1.46 [1.20-1.78],0.0002091638240954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XG,Glycoprotein Xg,23453,169,1.76 [1.22-2.54],0.0023229121837396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YOD1,Ubiquitin thioesterase OTU1,19476,122,0.64 [0.48-0.85],0.0019179657834404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZP4,Zona pellucida sperm-binding protein 4,19464,125,1.46 [1.01-2.11],0.0431625892012073
